Our growth and body composition development during early life can be predictors for our risk for obesity and non-communicable disease (NCDs) later in life.1Gluckman, et al. N Engl J Med, Published on 2008;359:61–73 , 2Hanley, et al. Br J Nutr, Published on 2010;104:S1S25 doi: 10.1017/S0007114510003338, 3Baird, et al. BMJ. Published on 2005;331:929 Maternal health and the quality of a mother’s diet are instrumental to the quality of foetal growth.4Godfrey et al. Trends Endocrin Metabol. Published on 2010;21(4):199-205. ,5Gluckman, et al. N Engl J Med, Published on 2008;359:61–73 Optimal growth during this stage, as well as during infancy and young childhood, reduces the risk for obesity and metabolic disease in later life for ‘at risk’ populations such as preterm infants, infants with low or high birth weight and infants from malnourished, obese or diabetic mothers.6Gluckman, et al. N Engl J Med, Published on 2008;359:61–73
At Danone Nutricia Research, we understand that by providing the right quality of nutrients during the first 1000 days, as well as the right quantity, we can support the optimal physical and metabolic development of infants and children, helping them to meet their full growth potential. We continually work to develop products that deliver optimal nutrition at each stage of development to ensure the best start in life.
|1, 5, 6||Gluckman, et al. N Engl J Med, Published on 2008;359:61–73|
|2||Hanley, et al. Br J Nutr, Published on 2010;104:S1S25 doi: 10.1017/S0007114510003338|
|3||Baird, et al. BMJ. Published on 2005;331:929|
|4||Godfrey et al. Trends Endocrin Metabol. Published on 2010;21(4):199-205.|
|7||WHO. Published on 2014 http://apps.who.int/iris/bitstream/10665/113048/1/WHO_NMH_NHD_14.1_eng.pdf|